Q1. Could you start by giving us a brief overview of your professional background, particularly focusing on your expertise in the industry?

I have spent over two decades building and scaling some of India's most recognised FMCG brands across categories as diverse as edible oils, foods, personal care, nutrition, and packaged staples. My career has taken me through leadership roles at Marico, Hindustan Unilever, Nestlé, and Ruchi Soya
— organisations that collectively define the playbook for brand-building in India. Across these stints, I have held P&L ownership, led large cross-functional teams, driven new product development from insight to shelf, and managed distribution across General Trade, Modern Trade, e-commerce, and rural channels.

What distinguishes my experience is the breadth of strategic and operational exposure — I have been equally comfortable in a boardroom crafting a five-year category vision and on the ground in a Tier 3 town diagnosing a distribution gap. I have led businesses through hyper-growth phases as well as through category disruption — moments that taught me that strategy without execution rigour is merely aspiration.

More recently, I transitioned into independent consulting, where I work with FMCG companies and investors as a Brand & Growth Consultant and strategic advisor. My work spans brand positioning, category creation, go-to-market strategy, D2C build-outs, channel economics, and organisational capability building. I also advise on investments, bringing a practitioner's lens to due diligence — evaluating not just financials, but the quality of brand equity, channel health, and management depth. I am currently engaged as Chief Growth Officer with McGill Foods, the company behind Eatopia, a brand operating in the health-forward foods space.

 

Q2. How is the health and wellness agenda evolving from a niche positioning to a mainstream growth driver in FMCG?

The shift from niche to mainstream in health and wellness is one of the most consequential structural changes I have witnessed in Indian FMCG in the last decade — and it is still far from complete.

For much of the 2000s and early 2010s, "healthy" was a premium positioning layered onto legacy products — think multigrain variants, low-fat dairy, or fortified atta. These were largely incremental plays, riding on consumer aspiration without fundamentally changing the product proposition. The consumer base was thin — urban, upper-income, and largely female. Distribution was shallow, price premiums were steep, and category trial was low.

What has changed structurally is the democratisation of health awareness, accelerated sharply by COVID-19. The pandemic created a before-and-after moment in consumer consciousness. Suddenly, immunity, gut health, clean labels, and ingredient transparency ceased to be topics confined to wellness enthusiasts on Instagram — they entered mainstream household conversations in Tier 1 and Tier 2 cities alike. The result was a fundamental rewiring of purchase intent: consumers began reading labels, scrutinising ingredient lists, and questioning the long-term cost of "cheap and convenient."

Several macro forces are sustaining this shift. Rising lifestyle disease prevalence — diabetes, obesity, hypertension — is creating urgency, not just aspiration. The growing middle class has more disposable income and is willing to trade up for perceived health value. Digital health awareness, driven by YouTube, health influencers, and doctor-creator content, has massively expanded the informed consumer base. And the rise of D2C brands has brought category education and product innovation at scale.

For FMCG companies, this means health can no longer be treated as a flanker strategy or an upward extension. It is increasingly the primary growth axis. Categories like honey, jams, breakfast cereals, dairy, oils, and snacking are being redefined around health credentials — natural sourcing, reduced sugar, added nutrition, and clean formulations. The companies that will win are those that can make health accessible, credible, and convenient — not just premium and aspirational.

 

Q3. How do you see the balance between functional health benefits and taste/convenience playing out in consumer decision-making?

This is perhaps the most operationally consequential tension in the health and wellness category — and it is one that brands consistently get wrong, in both directions.

The fundamental truth about the Indian consumer — and arguably the global consumer — is that they want health and taste, not health instead of taste. The "better-for-you" narrative collapses the moment the product disappoints at the point of consumption. I have seen well-funded health brands with strong clinical formulations fail at scale simply because the taste profile was not good enough to survive the household's second purchase. Trial is easy to buy; repeat is earned entirely through the in-mouth experience.

What the data and my on-ground experience consistently show is a tiered decision-making model. At the category entry point — the first purchase — health credentials and brand communication drive trial. The consumer is making a values-based decision: "I want to make a better choice." But from the second purchase onward, sensory experience takes over as the primary driver. Health becomes the permission to buy; taste becomes the reason to return.

Convenience adds a third critical dimension, particularly in urban markets where time scarcity is acute. A product that requires preparation, has short shelf life, or demands behavioural change in consumption routines faces an enormous adoption barrier regardless of its health story. The explosion of RTE (ready-to-eat) and RTC (ready-to-cook) health formats is a direct response to this — consumers are not willing to choose between health and ease.

The winning formula I advocate for is what I call the "Stealth Health" approach — embed functional benefits deep into a product that leads with taste, texture, and convenience in its primary communication. Brands that lecture consumers about health tend to attract the already-converted. Brands that delight consumers with great products and then reward them with health credentials build far larger, more durable franchises.

 

Q4. How is the rise of quick commerce and e-commerce influencing product formats, pricing, and innovation?

Quick commerce — and I use that term broadly to include platforms like Blinkit, Swiggy Instamart, and Zepto — is not merely a new channel. It is an innovation forcing function that is compelling FMCG companies to fundamentally rethink their product and commercial architecture.

Let me break this down across three dimensions.

Product Formats: Traditional FMCG was engineered for shelf stability, ambient logistics, and bulk pack sizes suited to monthly General Trade purchase cycles. Quick commerce has introduced an entirely new consumption occasion — the immediate, small-basket, impulse-driven purchase. This rewards smaller pack sizes, single-serve formats, and products that photograph well (since the primary point of discovery is a 4-inch screen). I have seen brands create quick-commerce-exclusive SKUs — not just repriced variants, but genuinely new formats designed for this channel's unique demand profile. In the health space particularly, single-serve shots, travel packs, and trial-size formats have found a natural home in q-commerce.

Pricing: Quick commerce has complicated pricing architecture significantly. The channel demands margin from all sides — brands face pressure to fund discounts and visibility, while also having to justify a price premium over kirana for the convenience value proposition. The risk is channel conflict: if a brand is available 30% cheaper on Amazon pantry than on Blinkit, it undermines the q- commerce value equation. Smart brands are addressing this through channel-specific pack architectures — a 250g "quick commerce pack" priced differently from a 500g "traditional trade pack," preserving MRP integrity while managing margin profiles.

Innovation: Perhaps most significantly, quick commerce data is becoming a powerful innovation input. The real-time demand signals available from these platforms — search terms, cart abandonment, basket co-purchases — are giving brands a level of consumer insight that was previously the preserve of large research studies. A brand that watches what consumers search for and fail to find on Blinkit has a real-time map of white spaces. This is transforming NPD timelines and dramatically shortening the gap between insight and launch.

The companies that treat quick commerce as merely a delivery channel are leaving enormous strategic value on the table.

 

Q5. How is sustainability intersecting with the health agenda in FMCG, particularly in sourcing and packaging?

The intersection of sustainability and health is one of the most intellectually rich, and commercially under-exploited, territories in FMCG today. I believe we are at the beginning of a convergence that will reshape category positioning over the next decade.

From a consumer psychology perspective, the health-conscious consumer and the sustainability- conscious consumer are increasingly the same person. The individual who reads ingredient labels is also more likely to be concerned about where those ingredients were sourced, how they were processed, and what happens to the packaging after consumption. This creates a powerful opportunity for brands to build a unified "good for me, good for the planet" narrative — but most have not yet done so coherently.

On the sourcing side, the most meaningful developments are happening in traceability and provenance. Consumers are increasingly willing to pay a premium for honey that is demonstrably single-origin, for oils that carry a verifiable cold-press certification, or for grains that carry an organic or regenerative agriculture claim. Blockchain-based traceability, while still nascent in India, is beginning to move from pilot to practice in premium categories. The health dimension is directly tied here — clean sourcing is increasingly understood by consumers as a proxy for nutritional integrity.

On the packaging side, the Indian market is navigating a genuine tension between sustainability ambition and commercial reality. Sustainable packaging — compostable films, recycled PET, paper- based mono-materials — typically carries a 15–40% cost premium, which is extremely difficult to absorb or pass on in price-sensitive categories. The companies making real progress are those treating packaging sustainability as a multi-year structured investment rather than a PR exercise, building supplier partnerships that can bring costs down through scale.

The regulatory environment is also accelerating this — Extended Producer Responsibility (EPR) norms under India's Plastic Waste Management rules are creating compliance urgency that is converting sustainability from a "nice to have" into a board-level agenda item.

My counsel to FMCG leaders is to stop treating health and sustainability as separate workstreams. Consumers are already connecting these dots — brand strategy should follow.

 

Q6. What role can AI play in identifying white spaces for new category creation rather than just optimizing existing ones?

This is a question I find genuinely exciting, because I believe most of the conversation around AI in FMCG is anchored at the wrong end of the value chain — optimising promotions, improving demand forecasting, reducing supply chain waste. These are real and meaningful applications, but they are fundamentally defensive. The more transformative opportunity lies in using AI as an offence mechanism — a tool for discovering what does not yet exist but should.

Let me explain what that looks like in practice.

Traditional category creation in FMCG follows a relatively slow, expensive pathway: ethnographic research, focus groups, concept testing, test markets. The cycle from insight to launch has historically been 18–36 months for a genuinely new category. AI is compressing this dramatically by processing unstructured signals at a scale no human team can match.

The most powerful application I have seen is unsupervised pattern recognition across consumer language data — mining social media conversations, search query data, online reviews, and community forums not for what consumers say about existing products, but for the language they use to describe unmet needs. When you see thousands of consumers using phrases like "I wish there was something that..." or "Why doesn't anyone make a..." — you are looking at a category that is waiting to be born. AI can surface these patterns in weeks rather than years.

A second powerful application is cross-category signal fusion — using AI to identify behaviours, ingredients, or positioning mechanisms that are gaining traction in adjacent markets (say, the US, South Korea, or Brazil) before they arrive in India, and stress-testing whether the conditions for adoption exist in the Indian consumer context. This is essentially an AI-powered cultural trend arbitrage.

Third, AI enables rapid hypothesis generation and concept prototyping — using generative models to create, iterate, and pre-screen dozens of product concepts at minimal cost before any physical R&D investment is made. This dramatically improves the quality of the shortlist that enters the innovation funnel.

What AI cannot replace is the qualitative depth of human insight — understanding the emotional, cultural, and contextual texture of consumer behaviour. The winning model is AI as a signal amplifier and hypothesis generator, with human expertise providing the interpretive judgment that converts signals into strategy.

 

Q7. If you were an investor looking at companies within the space, what critical question would you pose to their senior management?

If I were sitting across the table from a health and wellness FMCG management team with an investment decision to make, I would ask one question above all others:

"What is the repeat purchase rate of your hero SKU at 6 months, and what does your cohort data tell you about where you lose consumers?"

Everything else — the brand story, the TAM estimates, the distribution ambition — is forward- looking and, to varying degrees, speculative. Repeat purchase data is the closest thing to a ground truth in consumer goods. It tells you whether the product has genuinely earned its place in the consumer's life, or whether you are looking at a brand sustained by constant acquisition spending on a leaky bucket.

A high 6-month repeat rate — say, above 40% for a food or FMCG product — tells me the product has cracked the taste-health balance, fits into a real consumption routine, and has enough perceived value to overcome price sensitivity on repurchase. It tells me the brand is building genuine equity, not just buying transactions.

Conversely, cohort drop-off data is devastatingly informative. If a management team can tell me where in the consumption journey they lose consumers — after first purchase, after second, post a price increase, post a channel shift — it tells me how well they understand their own business.

Teams that do not have this data, or that cannot speak to it fluently, are flying blind. And in the health and wellness space — where consumer trial is relatively easy to generate through purpose- driven marketing but retention requires genuine product superiority — flying blind is fatal.

The secondary question I would ask, if time permitted, would be: "Which large FMCG player have you prepared for — and what is your defensibility strategy when they enter your category with their distribution and marketing muscle?" Because in India, if you are building something that works, the majors will come. Whether you have a moat — through formulation IP, community, sourcing exclusivity, or brand love that cannot be bought — is what separates a fundable business from a category pioneer who ends up fertilising someone else's growth.